39.75
2.72%
-1.11
Handel nachbörslich:
39.75
Finanzdaten der MoonLake Immunotherapeutics-Aktie (MLTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
15.81%
15.03
|
12.98 | 13.19 | 12.93 | 14.77 |
Operating Income/Loss |
15.81%
-15.03
|
-12.98 | -13.19 | -12.93 | -14.77 |
Income/Loss From Continuing Operations Before Tax |
32.33%
-7.8431
|
-11.59 | -12.35 | -12.22 | -14.73 |
Income Tax Expense/Benefit |
53.19%
0.0443
|
0.0289 | 0.0101 | 0.011 | 0.00874 |
Income/Loss From Continuing Operations After Tax |
32.12%
-7.8874
|
-11.62 | -12.35 | -12.22 | -14.74 |
Net Income/Loss
|
32.12%
-7.8874
|
-11.62 | -12.35 | -12.22 | -14.74 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
79.47%
-0.4503
|
-2.1933 | -2.2141 | -3.2141 | -4.6312 |
Basic Average Shares |
93.20%
3.6369
|
53.52 | 43.72 | 39.06 | 36.93 |
Diluted Average Shares |
93.20%
3.6369
|
53.52 | 43.72 | 39.06 | 36.93 |
Basic Earnings Per Share |
44.44%
-0.10
|
-0.18 | -0.23 | -0.23 | -0.27 |
Diluted Earnings Per Share |
44.44%
-0.10
|
-0.18 | -0.23 | -0.23 | -0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):